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In this review, we propose that age-related changes in mammographic density and breast tissue involution are closely related
phenomena, and consider their potential relevance to the aetiology of breast cancer. We propose that the reduction in
mammographic density that occurs with increasing age, parity and menopause reflects the involution of breast tissue. We further
propose that age-related changes in both mammographic density and breast tissue composition are observable and measurable
phenomena that resemble Pike’s theoretical construct of ‘breast tissue ageing’. Extensive mammographic density and delayed breast
involution are both associated with an increased risk of breast cancer and are consistent with the hypothesis of the Pike model that
cumulative exposure of breast tissue to hormones and growth factors that stimulate cell division, as well as the accumulation of
genetic damage in breast cells, are major determinants of breast cancer incidence.
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Henson and Tarone (1994) proposed that variations in the rate or
extent of the decrease in the number and size of breast lobules with
increasing age, referred to as breast tissue involution, might be an
important factor in the aetiology of breast cancer. They also drew
attention to similarities between the histological changes of
involution and changes in radiological features of the breast,
which were then described in terms of Wolfe’s patterns and are
now usually referred to as ‘mammographic density’.
Since then, there have been advances in our understanding of
the relationship between both breast histology and mammographic
density to the risk of breast cancer, and of the factors that
influence these features. Vachon et al (2007a) recently drew
attention to similarities between age-related breast involution and
mammographic density.
In this review, we discuss some of the literature related to
mammographic density, breast tissue involution, and breast cancer
risk. We propose that age-related changes in mammographic
density and breast involution are closely related phenomena, and
consider their potential relevance to the aetiology of breast cancer
in the light of the Pike model of mammary carcinogenesis.
MAMMOGRAPHIC DENSITY AND BREAST CANCER
RISK
The radiographic appearance of the breast varies among women of
the same age because of variations in breast tissue composition
(see further in ‘Age and breast tissue composition’ section below)
and the X-ray attenuation properties of the different types of tissue
(Johns and Yaffe, 1987). Fat attenuates X-rays least and appears
dark on a mammogram, whereas stroma and epithelium attenuate
X-rays more and appear white.
Wolfe (1976a,b) related these variations in the appearance of the
mammogram to the risk of breast cancer using a qualitative
classification with four categories: N1 for breast tissue comprising
mainly fat; P1 and P2 for the appearance of ductal prominence
of less than 25% or greater than 25%, respectively, or more of the
breast area; and DY extensive ‘dysplasia’. Subsequently, the
American College of Radiology introduced the BI-RADS classifica-
tion with four categories: (1) almost entirely fat (low density); (2)
scattered fibroglandular densities (average density); (3) hetero-
geneously dense (high density); and (4) extremely dense (very high
density) (American College of Radiology (ACR), 2003). Most well-
designed epidemiological studies have found that Wolfe’s classi-
fication and the BI-RADS system do identify individuals at
different risks for breast cancer (Saftlas and Szklo, 1987; Oza and
Boyd, 1993; Ziv et al, 2004), but quantitative methods that measure
and express the area of dense tissue as a percent of the area of the
breast in the image have, in general, given more consistent results
and created larger gradients of risk (Warner et al, 1992;
McCormack and dos Santos Silva, 2006).
As reviewed recently by McCormack and dos Santos Silva
(2006), at least 15 independent studies that used quantitative
methods to assess mammographic density (10 case–control
studies and 5 cohort studies) with a total of 6274 cases of breast
cancer and 11638 controls have been published to date. Although
methods of measurement and definitions of density vary among
studies, women with density in more than 60–75% of the breast
have consistently been found to have a four- to six-fold greater
risk of breast cancer than women with little or no density. Risk
estimates were larger in studies that used percent density rather
than Wolfe or BI-RADS classifications, and associations between
density and risk were 20–30% stronger in studies with incident
rather than prevalent cancers.
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www.bjcancer.comExtensive breast density is therefore one of the strongest known
risk factors for developing breast cancer, second only to age
and carrying a BRCA1 or BRCA2 mutation. Although less than 5%
of unselected breast cancer patients have a BRCA1 or BRCA2
mutation, extensive mammographic density is common among
women with breast cancer, and estimates of attributable risk show
that densities in more than 50% of the breast may account for
about a third of all breast cancers (Byrne et al, 1995; Boyd et al,
2007).
A previous study has shown that extensive mammographic
density is also strongly associated with the risk of benign breast
disease. Compared to women with no density, risk of hyperplasia
without atypia was increased 12.2-fold (95% CI: 2.97–50.14), and
that of atypical hyperplasia and in situ breast cancer increased 9.7-
fold (95% CI: 1.75–53.97) in women with density in more than
75% of the mammogram (Boyd et al, 1992).
Percent mammographic density is less extensive in parous than
in nulliparous women and in postmenopausal than premenopausal
women, and it is inversely associated with body weight (reviewed
by Boyd et al, 2005). Cross-sectional and longitudinal studies
show that average percent mammographic density declines with
increasing age (Figure 1) (Maskarinec et al, 2006; Martin and Boyd,
2008). This may seem paradoxical as breast cancer risk increases
with age. However, we have proposed that this apparent paradox
can be resolved by reference to the concept of ‘breast tissue age’
described by Pike and discussed in the next section.
AGE AND BREAST CANCER INCIDENCE
In 1983, Pike proposed a model that accounted for the effect of the
principal reproductive and endocrine risk factors for breast cancer
on the incidence of the disease. The model is based on the concept
that the rate of ‘breast tissue ageing’, rather than chronological age,
is the relevant measure for describing the effects of ‘hormonal’ risk
factors on the age-specific incidence of breast cancer (Pike et al,
1983). The concept of ‘breast tissue ageing’ is related to the effects
of hormones on the kinetics of breast cells and the associated
accumulation of genetic damage. As shown in Figure 2A, the rate
of ‘breast tissue ageing’ is most rapid at the time of menarche,
slows with each pregnancy, slows further in the perimenopausal
period, and is least after the menopause. After fitting suitable
numerical values for these parameters, Pike showed that cumula-
tive exposure to ‘breast tissue ageing’, given by the area under the
curve in Figure 2A, described the age-incidence curve for breast
cancer in the United States, shown in Figure 2B. The general
properties of the model have since been confirmed by observation
when applied to the Nurses Health Study by Rosner and Colditz
(1996), who extended the model initially to include the effects of
number and spacing of pregnancies and subsequently to include
other non-reproductive risk factors.
AGE AND BREAST TISSUE COMPOSITION
Increasing age is associated with a reduction in glandular tissue
and an increase in fat in the breast. For example, Gertig et al (1999)
found in surgical biopsies sampled from the Nurses Health Study
that the proportion of the biopsy occupied by both the epithelium
and stroma deceased with increasing age at biopsy. This tissue was,
however, taken from regions of the breast known or suspected to
contain disease.
Breast tissue not sampled from sites of breast disease was
obtained by Bartow et al using forensic autopsy material from 519
women examined in the New Mexico Office of the Medical
Investigator between 1978 and 1983. After subcutaneous mastect-
omy, whole breast mammograms were obtained and the specimens
sectioned at 1cm intervals. Tissue slices were examined with high-
dose non-screen radiography, and random samples were taken for
histological examination (Bartow et al, 1987). Using this material,
Li et al (2005) carried out a histological evaluation of 236 subjects,
sampled according to mammographic density and age. Quantita-
tive microscopy was used to measure both the nuclear area of
epithelial and non-epithelial cells and the areas of glandular tissue
and collagen. Details of the methods used are given elsewhere.
Statistically significant inverse associations were found between
age and each of the breast tissue measurements (Figure 3). These
associations were not changed by adjustment for weight or BMI,
except percent collagen, where the inverse association with age
became stronger after adjustment (data not shown).
The study of Li et al (2005) showed an association between each
of the breast tissue features measured and percent mammographic
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Figure 1 Percent mammographic density vs age. (A) Baseline percentage mammographic density in women from three mammographic screening
programmes. Reproduced with kind permission of BioMed Central from Martin and Boyd, 2008. (B) Unadjusted mean percent density as a function of age
group and case status. Reproduced with kind permission of American Association for Cancer Research from Maskarinec et al, 2006.
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taken (Figure 3 right-hand panels). Greater percent density was
statistically significantly associated with a greater proportion of
collagen, glandular structures, and total nuclear area (as well as
epithelial and non-epithelial nuclear area, data not shown). The
risk factors that were found on univariate analysis (adjusted for
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Figure 2 Breast tissue ageing (A) and the age-specific incidence of breast cancer (B). Reproduced with kind permission of Nature Publishing Group from
Pike et al, 1983.
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Figure 3 Boxplots of histological measures vs age (left hand panels); and histological measures vs percent density (right hand panels), data from Boyd and
colleagues (unpublished).
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associated, in the same direction, with measures of breast tissue
(see Li et al, 2005). Age, body mass index, and postmenopausal
status were significantly and inversely associated with mammo-
graphic density and all of the breast tissue measurements. Weight
was also negatively associated with all of the tissue measurements,
except for glandular area. Parity and number of births were
associated inversely only with percent collagen.
BREAST TISSUE COMPOSITION AND RISK OF
BREAST CANCER
The association between the type of tissue in the breast and the
risk of breast cancer has been described extensively. Women
diagnosed with carcinoma in situ and atypical hyperplasia or
hyperplasia without atypia have an approximately 9.4, and 1.5
times, respectively, greater risk of developing invasive breast
cancer when compared to the general population of women of the
same age (Dupont and Page, 1985; Hartmann et al, 2005).
More recently, a quantitative classification of breast tissue has
been shown to be related to breast cancer risk. Milanese et al
(2006) examined the risk of breast cancer associated with
variations in lobular involution in the Mayo Benign Breast Disease
Cohort of 8736 women with benign breast disease who had
biopsies between 1967 and 1991, and who had subsequently been
followed for a median of 17 years. All slides were reviewed by
a breast pathologist ‘blinded’ to the patient’s age, cancer outcome,
or original histological diagnosis. Involution in the biopsy
was classified into one of three categories according to the extent
of lobular involution in the terminal duct lobular units (TDLUs)
in the background tissue as: none (0% TDLUs involuted), partial
(1–74% TDLUs involuted), or complete (X75% TDLUs involuted).
Complete lobular involution was present in 5.8% of women aged
40–49 years and in 21.6% of women aged 50–59 years, and the
degree of involution was greater in nulliparous than in parous
women. (As noted above, parity has been found in the study of
Li et al to be inversely associated with collagen but not with
other tissue components–see ‘Age and breast tissue composition’
section.)
Risk of breast cancer associated with variations in lobular
involution was calculated with reference to expected age-specific
breast cancer incidence rates from the Iowa SEER registry.
Compared to the Iowa SEER population, the relative risk (RR)
of breast cancer was 1.88 (95% CI 1.59–2.21) for those with no
involution, 1.47 (95% CI 1.30–1.51) for those with partial
involution, and 0.91 (95% CI 0.75–1.10) for those with complete
involution.
Lobular involution was associated with risk of breast cancer
independently of other histological, reproductive, and demo-
graphic risk factors for the disease, but mammographic density
was not among the risk factors considered. The extent of lobular
involution modified risk in all of the subsets examined, most
notably for women with cellular atypia on biopsy, where the RRs
were 7.79 (95% CI 3.56–14.81) for those with no involution and
1.49 (95% CI 0.41–3.81) for those with complete involution.
MAMMOGRAPHIC DENSITY, INVOLUTION, AND
‘BREAST TISSUE AGE’
Mammographic density shares many of the features of ‘breast
tissue age’ in the Pike model. Density is greatest at early ages,
declines with increasing age, and is reduced by successive
pregnancies and menopause (Boyd et al, 2002a). Similar to the
concept of ‘breast tissue age’, mammographic density and the
involution of breast epithelium and stroma are influenced by
similar factors, including age, parity and menopause, and changes
in these tissue components are reflected in changes in mammo-
graphic density. As suggested by the Pike model, cumulative
exposure to mammographic density, breast lobules, and stroma
that are responsible for radiological density may thus reflect
cumulative exposure to hormones and growth factors that
stimulate cell division in breast tissue and also be an important
factor underlying the age-specific incidence of breast cancer.
Longitudinal studies of mammographic density support the
concept that cumulative exposure is greater in those who develop
breast cancer than in controls. Two longitudinal studies have
examined the relationship between change in density and breast
cancer risk, one over an average of 4–5 years (Maskarinec et al,
2006) and the other over an average of 7 years (Vachon et al,
2007a). Both used computer-assisted quantitative measurement of
mammographic density and both showed that change in density
with time was similar in women who developed breast cancer and
those who remained free of disease (an example is shown in
Figure 1B), but that at all ages, density was more extensive in
women who develop breast cancer. Kerlikowske et al (2007), in a
further longitudinal study reported that an increase in BI-RADS
category in two mammograms at least 9 months and an average of
3 years apart was associated with a higher risk of breast cancer,
and a decrease in category with a lower risk.
It is not clear at present to what extent these differences in
results from longitudinal studies reflect differences in the
menopausal status of the subjects studied, observer variation in
the use of a qualitative method of assessing density, technical
variations in mammography, or changes in the affected breast
preceding the diagnosis of breast cancer.
With the exception of the study of Kerlikowske, the available
evidence suggests that it is the extent of density at a given age,
rather than the rate of change of density with increasing age, that is
related to breast cancer risk (Maskarinec et al, 2006; Vachon et al,
2007a). However, there are important gaps in knowledge concern-
ing cumulative exposure. We have little information about the
factors that influence breast tissue characteristics at early ages, and
it is also unclear whether interventions that reduce cumulative
exposure will reduce the risk of breast cancer. Mammographic
density and breast tissue involution are both associated with the
risk of breast cancer independently of the other risk factors of age,
parity, and menopausal status. It is not, however, known if the
effects on breast cancer risk of mammographic density and breast
tissue involution are independent of each other.
Reproductive and menstrual risk factors and body weight
explain only 20–30% of the variation in density (Vachon et al,
2000). Twin studies have shown that genetic factors have a large
function in explaining variation in mammographic density (Boyd
et al, 2002b; Stone et al, 2006), and that after adjusting for age,
parity, menopausal status, and body weight, an additive genetic
model explained about 60% of the residual variance in percent
density. The genetic factors that influence mammographic density
may also explain variations in breast tissue involution.
LIMITATIONS OF EXISTING STUDIES OF
MAMMOGRAPHIC DENSITY, INVOLUTION, AND
BREAST CANCER RISK
Our current understanding of the risks of breast cancer associated
with both mammographic density and breast tissue involution may
be underestimates. The risk of breast cancer associated with
mammographic density is likely to be underestimated because of
the limitations in all of the existing methods of measurement.
None takes into account the thickness of the breast, and all are
thus based on the projected area rather than the volume of breast
tissue. Current computer-assisted methods of measurement
require that a dichotomous threshold be placed between dense
and non-dense tissue, and do not allow for a gradual change in
tissue composition, as is likely to exist in reality (Boyd et al, 2005).
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and other limitations are in progress and may improve risk
discrimination and strengthen a aetiological associations.
The risk of breast cancer associated with breast involution may
also be underestimated. The data of Milanese et al are based
necessarily on women who had biopsies. It seems likely that
women in whom involution is most complete may also be less
likely to have signs or symptoms that would prompt breast biopsy.
Further, the definition of involution used by Milanese et al was
based solely on the histology of breast lobules. As we show above,
both the epithelium and stroma change with age, and both types of
tissue may be relevant to carcinogenesis in the breast (Tlsty and
Hein, 2001). Further, the use of quantitative methods to assess
these tissues may provide more information than the three-
category system used to date.
POTENTIAL BIOLOGICAL MECHANISMS
We have described in detail elsewhere a hypothesis, based on
existing epidemiological evidence, to account for the association of
mammographic density with the risk of breast cancer (Martin and
Boyd, 2008), which we outline briefly here.
As we have discussed earlier, there is now extensive evidence
that mammographic density is an independent risk factor for
breast cancer that is associated with large relative and attributable
risks for the disease. The epidemiology of mammographic density,
including the influences of age, parity, and menopause, is
consistent with it being a marker of susceptibility to breast cancer,
similar to the concept of ‘breast tissue age’ described by the Pike
model. Mammographic density reflects variations in the tissue
composition of the breast. It is associated positively with collagen
and epithelial and non-epithelial cells and negatively with fat.
Mammographic density is influenced by some hormones and
growth factors, as well as by several hormonal interventions. It is
also associated with urinary levels of a mutagen. Twin studies have
shown that most of the variation in mammographic density is
explained by genetic factors.
The hypotheses that we have developed from these observations
postulate that the combined effects of cell proliferation (mito-
genesis) and genetic damage to proliferating cells by mutagens
(mutagenesis) may underlie the increased risk of breast cancer
associated with extensive mammographic density. There is clearly
a need for an improved understanding of the specific factors that
are involved in these processes and of the role played by the
several breast tissue components that contribute to density.
In particular, the identification of the genes and their biological
functions, which are responsible for most of the variance in
percent density, is likely to provide insights into the biology of the
breast and may identify potential targets for preventive strategies
for breast cancer. In the light of the other similarities with
mammographic density described above, similar genetic factors
may be responsible for the variations in breast tissue involution
that are also associated with differences in the risk of breast cancer.
POTENTIAL FUTURE DIRECTIONS
In this paper, we have proposed that the changes in mammo-
graphic density that occur with increasing age, parity, and
menopause, as well as lobular involution in the breast, are closely
related phenomena that both resemble Pike’s theoretical concept
of ‘breast tissue ageing’. Extensive mammographic density for a
given age and delayed breast involution are both associated with
an increased risk of breast cancer and are consistent with the
hypotheses of the Pike model that the cumulative exposure of
breast tissue to hormones and growth factors that stimulate cell
division, as well as the accumulation of genetic damage in breast
cells, are major determinants of breast cancer incidence.
There are, however, several gaps in our knowledge of these risk
factors. Breast involution has to date been defined only in terms of
breast lobules. The effects of extending the definition of involution
beyond breast lobules to include stroma have not yet been
examined. Both the epithelium and stroma are influenced by age,
parity, and menopause, and stroma is known to have a function in
the development and maintenance of the epithelium through
paracrine growth stimuli and is thought to have a function in
mammary carcinogenesis (Tlsty and Hein, 2001; Nelson and
Bissell, 2006).
The relationship between mammographic density and histolo-
gical definitions of involution in individuals, although suggested
by the histological studies referred to above, has not yet been
explicitly examined, and it is not known whether histological
definitions of involution predict breast cancer risk independently
of mammographic density.
It is quite likely that within the next few years the principal
genetic variants that are associated with differences in mammo-
graphic density will be identified (Vachon et al, 2007b). These
variants may help to identify biological pathways in the breast that
are associated with variations in the epithelial and stromal tissues
that participate in the process of involution. Some of these genes
may also influence the risk of breast cancer.
REFERENCES
American College of Radiology (2003) American College of Radiology
(ACR) Breast Imaging Reporting and Data System (BI-RADS), 4th edn.
Reston, VA
Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR (1987) Prevalence of
benign, atypical and malignant breast lesions in populations at different
risk for breast cancer. A forensic autopsy study. Cancer 60: 2751–2760
Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M (2002a) A
longitudinal study of the effects of menopause on mammographic
features. Cancer Epidemiol Biomarkers Prev 11: 1048–1053
Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G,
Chiarelli A, Minkin S, Yaffe M (2007) Mammographic density and the
risk and detection of breast cancer. N Engl J Med 356: 227–236
Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MRE, Giles
GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL (2002b) Heritability of
mammographic density, a risk factor for breast cancer. N Engl J Med 347:
886–894
Boyd NF, Jensen H, Cooke G, Lee Han HW (1992) Relationship between
mammographic and histological risk factors for breast cancer. J Natl
Cancer Inst 84: 1170–1179
Boyd NF, Rommens JM, Vogt K, Hopper JL, Lee V, Yaffe MJ, Paterson M
(2005) Mammographic breast density as an intermediate phenotype for
breast cancer. Lancet 6: 798–808
Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R,
Haile R (1995) Mammographic features and breast cancer risk: effects
with time, age, and menopause status. J Natl Cancer Inst 87: 1622–1629
Dupont WD, Page DL (1985) Risk factors for breast cancer in women with
proliferative breast disease. N Engl J Med 312: 146–151
Gertig DM, Stillman IE, Byrne C, Spiegelman D, Schnitt SJ, Connolly JL,
Colditz GA, Hunter DJ (1999) Association of age and reproductive
factors with benign breast tissue composition. Cancer Epidemiol
Biomarkers Prev 8: 873–879
Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K,
Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ,
Johnson J, Tlsty T, Vachon CM, Melton III JL, Visscher DW (2005)
Benign breast disease and the risk of breast cancer. N Engl J Med 353:
229–237
Henson DE, Tarone RE (1994) Involution and the etiology of breast cancer.
Cancer 74: 424–429
Mammographic density and breast cancer risk
OM Ginsburg et al
1373
British Journal of Cancer (2008) 99(9), 1369–1374 & 2008 Cancer Research UKJohns PC, Yaffe MJ (1987) X-ray characterisation of normal and neoplastic
breast tissues. Phys Med Biol 32: 675–695
Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-
Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R, National
Institutes of Health Breast Cancer Surveillance Consortium (2007)
Longitudinal measurement of clinical mammographic breast density to
improve estimation of breast cancer risk. J Natl Cancer Inst 99: 386–395
Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao M, Khokha R,
Martin L, Boyd NF (2005) The association of measured breast tissue
characteristics with mammographic density and other risk factors for
breast cancer. Cancer Epidemiol Biomarkers Prev 14: 343–349
Martin LJ, Boyd N (2008) Potential mechanisms of breast cancer risk
associated with mammographic density: hypotheses based on epidemio-
logical evidence. Breast Cancer Res 10: 1–14
Maskarinec G, Pagano I, Lurie G, Kolonel LN (2006) A longitudinal
investigation of mammographic density: the multiethnic cohort. Cancer
Epidemiol Biomarkers Prev 15: 732–739
McCormack VA, dos Santos Silva I (2006) Breast density and parenchymal
patterns as markers of breast cancer risk: A meta-analysis. Cancer
Epidemiol Biomarkers Prev 15: 1159–1169
Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney
SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA,
Melton III JL, Goode EL, Visscher DW (2006) Age-related lobular
involution and risk of breast cancer. J Natl Cancer Inst 98: 1600–1607
Nelson CM, Bissell MJ (2006) Of extracellular matrix, scaffolds, and
signaling: tissue architecture regulates development, homeostasis, and
cancer. Annu Rev Cell Dev Biol 22: 287–309
Oza AM, Boyd NF (1993) Mammographic parenchymal patterns: a marker
of breast cancer risk. Epidemiol Rev 15: 196–208
Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983)
‘Hormonal’ risk factors, ‘breast tissue age; and the age-incidence of
breast cancer. Nature 303: 767–770
Rosner B, Colditz G (1996) Nurses’ Health Study: log-incidence mathema-
tical model of breast cancer incidence. J Natl Cancer Inst 88: 359–364
Saftlas AF, Szklo M (1987) Mammographic parenchymal patterns and
breast cancer risk. Epidemiol Rev 9: 146–174
Stone J, Dite GS, Gunasekara A, English DR, McCredie MR, Giles GG,
Cawson JN, Hegele RA, Chiarelli AM, Yaffe MJ, Boyd NF, Hopper JL
(2006) The heritability of mammographically dense and nondense breast
tissue. Cancer Epidemiol Biomarkers Prev 15: 612–617
Tlsty TD, Hein PW (2001) Know thy neighbor: stromal cells can contribute
oncogenic signals. Curr Opin Genet Dev 11: 54–59
Vachon CM, Kuni CC, Anderson K (2000) Association of mammographi-
cally defined percent breast density with epidemiologic risk factors for
breast cancer (United States). Cancer Causes Control 11: 653–662
Vachon CM, Pankratz VS, Scott CG, Maloney SD, Ghosh K, Brandt KR,
Milanese T, Carston MJ, Sellers TA (2007a) Longitudinal trends in
mammographic percent density and breast cancer risk. Cancer Epidemiol
Biomarkers Prev 16: 921–928
Vachon CM, Sellers TA, Carlson EE, Cunningham JM, Hilker CA, Smalley
RL, Schaid DJ, Kelemen LE, Couch FJ, Pankratz VS (2007b) Strong
evidence of a genetic determinant for mammographic density, a major
risk factor for breast cancer. Cancer Res 67: 8412–8418
Warner E, Lockwood G, Tritchler D, Boyd NF (1992) The risk of breast
cancer associated with mammographic parenchymal patterns: a meta-
analysis of the published literature to examine the effect of method of
classification. Cancer Detect Prev 16: 67–72
Wolfe JN (1976a) Breast patterns as an index of risk for developing breast
cancer. Am J Roentgenol 126: 1130–1139
Wolfe JN (1976b) Risk for breast cancer development determined by
mammographic parenchymal pattern. Cancer 37: 2486–2492
Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K
(2004) Mammographic density and estrogen receptor status of breast
cancer. Cancer Epidemiol Biomarkers Prev 13: 2090–2095
Mammographic density and breast cancer risk
OM Ginsburg et al
1374
British Journal of Cancer (2008) 99(9), 1369–1374 & 2008 Cancer Research UK